Transplantation in end-stage pulmonary hypertension (Third international right heart failure summit, part 3)

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


The Third International Right Heart Summit was organized for the purpose of bringing an interdisciplinary group of expert physician-scientists together to promote dialogue involving emerging concepts in the unique pathophysiology, clinical manifestation, and therapies of pulmonary vascular disease (PVD) and right heart failure (RHF). This review summarizes key ideas addressed in the section of the seminar entitled “Transplantation in End-Stage Pulmonary Hypertension.” The first segment focused on paradigms of recovery for the failing right ventricle (RV) within the context of lung-alone versus dual-organ heart-lung transplantation. The subsequent 2-part section was devoted to emerging concepts in RV salvage therapy. A presentation of evolving cell-based therapy for the reparation of diseased tissue was followed by a contemporary perspective on the role of mechanical circulatory support in the setting of RV failure. The final talk highlighted cutting-edge research models utilizing stem cell biology to repair diseased tissue in end-stage lung disease—a conceptual framework within which new therapies for PVD have potential to evolve. Together, these provocative talks provided a novel outlook on how the treatment of PVD and RHF can be approached.

Original languageEnglish
Pages (from-to)717-727
Number of pages11
JournalPulmonary Circulation
Issue number4
StatePublished - Dec 2014
Externally publishedYes


  • Pulmonary hypertension
  • Pulmonary vasculature
  • Right ventricle
  • Right-heart failure
  • Transplantation


Dive into the research topics of 'Transplantation in end-stage pulmonary hypertension (Third international right heart failure summit, part 3)'. Together they form a unique fingerprint.

Cite this